Liontrust Investment Partners’s Amgen AMGN Stock Holding History

Liontrust Investment Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$4.8M	Buy	+20,890	New	+$4.82M	0.1%	111

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Liontrust Investment Partners's AMGN Position: Q4 2020 in Review

Liontrust Investment Partners opened a new position in Amgen (AMGN) in Q4 2020: 20,890 shares worth $4.8M. The stake represents 0.1% of the portfolio and ranks #111 among its holdings.

2,219 funds tracked by Wall St. Rank hold AMGN as of Q4 2020.

Liontrust Investment Partners held 20,890 shares of Amgen worth $4.8M as of Q4 2020.
Amgen was a new Liontrust Investment Partners position in Q4 2020.
Amgen made up 0.1% of Liontrust Investment Partners's portfolio in Q4 2020, its #111 holding.
2,219 funds tracked by Wall St. Rank held Amgen as of Q4 2020.

Based on Liontrust Investment Partners's 13F filing for Q4 2020, filed 10 Feb 2021.